BlackRock, Inc. 13D and 13G filings for Eledon Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-27 4:12 pm Purchase | 2026-03-31 | 13G | ELEDON PHARMACEUTICALS INC ELDN | BlackRock Inc. BLK | 4,380,857 5.800% | 755,033 (+20.82%) | Filing |
| 2026-01-21 12:30 pm Purchase | 2025-12-31 | 13G | ELEDON PHARMACEUTICALS INC ELDN | BlackRock Inc. BLK | 3,625,824 4.600% | 372,914 (+11.46%) | Filing |
| 2025-07-17 7:54 pm Purchase | 2025-06-30 | 13G | ELEDON PHARMACEUTICALS INC ELDN | BlackRock Inc. BLK | 3,252,910 5.400% | 3,252,910 (New Position) | Filing |